Anti-hepatitis C Activity of Meso-tetrakis-porphyrin Analogues
The present invention relates to porphyrin analogues, their use in pharmaceutical compositions alone, or combination with other agents and in the treatment and/or prophylaxis of flaviviridae viral infections, especially hepatitis C viral infection, and secondary disease states and/or conditions associated with same.
Patents:US 20,110,064,694
Inventor(s):
HAMILTON ANDREW [GB]; CHENG YUNG-CHI [US]
Type of Offer:
Sale
« More Pharmaceutical Patents